Yes, I looked at the company behind it. Please be careful. There have been some interesting legal fights with the directors feathering their own nests.
As you say one for the back burner.
The problem is that trials take so long with mCRC. SRX did their first small trials nearly 15 years ago. And although it is currently a long shot, should SIRT become included in SOC then any new product would have a huge mountain to climb to get a phase III trial to fruition.
SRX Price at posting:
$29.41 Sentiment: Buy Disclosure: Held
